Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Romania excludes sending troops to Ukraine
MENAFN
(MENAFN) Romanian Prime Minister Ilie Bolojan has firmly stated that Bucharest will not send troops to Ukraine under any circumstances.
Romania Rules Out Sending Troops to Ukraine
MENAFN
(MENAFN) Bucharest has firmly stated it will not dispatch troops to Ukraine under any conditions, Prime Minister Ilie Bolojan declared.
Europe Clinical Nutrition Market Set to Reach $36.63B by 2033, Driven by Chronic Illness Care & Personalized Solutions
EIN Presswire
Rising chronic diseases, aging populations, and innovation in personalized nutrition propel Europe’s clinical nutrition market growth through 2033. AUSTIN, TX, UNITED STATES, September 29, 2025 /EINPresswire.com/ -- The Europe clinical nutrition...
Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial
GlobeNewswire, Inc.
STAFFORD, Texas, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium
GlobeNewswire, Inc.
STAFFORD, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial
GlobeNewswire, Inc.
STAFFORD, Texas, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
Gold Nanoparticles and DNA, a Revolutionary Duo for Medicine: Nanoconjugates in the Fight with Cancer and Other Diseases
EIN Presswire
The nanoconjugates, known as nanobeacons and nano-flares, open up new horizons for rapid and accurate disease diagnosis and targeted therapies.
TCN Launches AI-Powered SmartAMD
EIN Presswire
LONDON, UNITED KINGDOM, June 9, 2026 /EINPresswire.com/ -- BUCHAREST, ROMANIA AND ST. GEORGE, UTAH, USA - TCN Inc., a global leader in cloud-based call centre platform solutions, today announced the successful launch of its new Smart Answering...
New Clinical Results Highlight the Skincare Potential of Baltic Bladderwrack in Finnish Innovation by Saaren Taika
EIN Presswire
Independent lab results show Baltic bladderwrack has double to triple the actives of Atlantic seaweed, powering Finland’s next skincare breakthrough.
Er-Kim Enters Commercialization Agreement with Sentynl Therapeutics for Nulibry® (fosdenopterin) and Zokinvy® (lonafarnib), Targeting Ultra-Rare Diseases
GlobeNewswire, Inc.
ATHENS, Greece and SOLANA BEACH, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies in EMEA region, today announced that it has signed an agreement...
Serratia Marcescens Outbreak Kills Six Infants in Romania Hospital
MENAFN
(MENAFN) Six infants have died and three more have tested positive following a Serratia marcescens outbreak at the Sfanta Maria Children's Hospital in the northeastern Romanian city of Iasi, the country's Health Ministry announced Friday.
EMBRACE Future launches #KnowEmotions Public Awareness-Raising Campaign on Children’s Mental Health
EIN Presswire
BUCHAREST, ROMANIA, September 11, 2025 /EINPresswire.com/ -- The EMBRACE project team is proud to announce the launch of its Public Awareness-Raising Campaign (PAC), running from October 2025 until April 2026. The campaign, under the motto...
Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland
GlobeNewswire, Inc.
STAFFORD, Texas, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
ECDC Warns: Drug-Resistant Fungus Spreads Across Europe Hospitals
MENAFN
(MENAFN) The European Centre for Disease Prevention and Control (ECDC) confirmed Thursday that a dangerous, drug-resistant fungus is making alarming inroads within hospitals across Europe.
Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial
GlobeNewswire, Inc.
European expansion in September across Georgia, Italy, Lithuania, Poland, Romania, Spain, and US 13 subjects recruited (treated, enrolled, or screened) Forecasts total recruitment of 20 or more subjects by end of September On track to recruit to...
Lexicon Pharmaceuticals to Present Additional Clinical Data on Pilavapadin at Three Upcoming Medical Meetings
GlobeNewswire, Inc.
Presentations collectively highlight pilavapadin’s potential to improve pain management care for patients with diabetic peripheral neuropathic pain (DPNP) Breadth of the data across Phase 2 program to be discussed at Arrowhead’s 19th Annual Pain...
Cord Blood Banking Services Market Size Expected to Reach USD 5.81 Billion by 2034 Driven by Regenerative Medicine and Chronic Disease Therapies
GlobeNewswire, Inc.
Ottawa, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The worldwide cord blood banking services market size is expected to reach approximately USD 5.81 billion by 2034, increasing from USD 3.27 billion in 2025. The market is growing at a compound annual...
Report on fact-finding visit to Romania
European Council on Refugees and Exiles (ECRE)
ECRE has published a report of its fact-finding visit to Romania.
AIDA Country Report on Romania – Update on 2024
European Council on Refugees and Exiles (ECRE)
|Published on: 27th August 2025|Categories: News| The updated AIDA Country Report on Romania provides a detailed overview on legislative and practice-related developments in asylum procedures, reception conditions, detention of asylum applicants...
Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania
GlobeNewswire, Inc.
STAFFORD, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
Sign up for:
Wellness Journal Romania
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.